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ABSTRACT
Objective: To assess the osteoinductive action of platelet-rich 
plasma when associated to ceramics in the spine of rats. Material 
and method: Laminectomy was performed in 16 isogenic Lewis 
rats for posterior ceramic grafting. PRP was prepared intraopera-
tively using blood collected from two other rats. Study and control 
groups were set by randomization, with the study group receiv-
ing ceramics associated to PRP, and the control group receiving 
only ceramics. The animals were sacrificed for histopathological 
analysis after 10 weeks. Results: Strong osteoblastic and osteo-
clastic activity and full re-absorption of ceramics were found on 
study group. In control group, small bone islands across fibrous 
tissue and non-reabsorbed were seen. Discussion: growth fac-
tors released by platelets bind to osteoblasts and fibroblasts 
surfaces, stimulating collagen synthesis to form bone matrix. 
Activated macrophages keep releasing growth factors and stimu-
lating osteogenesis. Conclusion: The use of PRP associated to 
ceramics showed stronger osteoblastic and osteoclastic activity 
and full ceramics re-absorption compared to standalone grafting 
on the spine of rats.
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INTRODUCTION
Surgical arthrodesis interventions are becoming increasingly 
popular in the practice of surgeons involved with the treatment 
of spine conditions, notably in the last twenty years. The under-
standing of spine biomechanics and the development of surgical 
techniques and rigid instrumentation materials led to the rational-
ization of these procedures, making them easier to perform, less 
morbid e more effective, with resultant reduction of hospitaliza-
tion time and better postoperative recovery of patients.
Bone fusion process is critical for postoperative stabilization of 
spinal arthrodesis. For that, the use of grafting material favoring 
bone neoformation between osteotomized vertebral segments is 
required during surgical procedure. Bone bridges leading to fu-
sion and, subsequently, to spine stabilization involve a number of 
physiopathological events in which osteoprogenitor mesenchy-
mal cells are activated by inducing growth factors differentiating 
into osteoblasts, responsible for osteogenesis and subsequent 
remodeling along a structurally conductive surface.
Autologous bone graft serves as an optimal material for grafting 
for presenting three major properties: presence of osteogenic 
cells, osteoconductive structure and osteoinductive matrix. No 
other material comprises all advantages mentioned above1. Au-
tologous grafting implies in higher operative morbidity to obtain 
a small amount of graft, hence the need of seeking biomaterial 
alternatives favoring bone fusion in arthrodeses. The most fre-
quently employed ones today are ceramics, homologous bone 
grafts and demineralized bone matrix. These are usually em-
ployed in combination with autologous graft or added to other 
materials providing them osteoinductive properties: the growth 
factors.2
Many factors interfere on bone fusion process and extend be-
yond grafting material properties. Local biomechanical changes 
resulting in instability impair bone neoformation process. The 
mineralization status of the host bed, the presence of local patho-
logic changes such as ischemia, infections and neoplasms, as 
well as hormonal unbalances, use of drugs and toxic substances 
(notably tobacco) are worsening factors that negatively interfere 
on the bone fusion process.3-6 Therefore, it is understandable 
that fusion failure rates on intertransversal lumbar arthrodeses, 
just to mention one of the most common approaches for the 
treatment of lumbar spine injuries, range from 5 to 35%.5
Several research lines and clinical studies currently address 
this issue, pursuing the optimal graft: a material containing os-
teoinductive, osteogenic and osteoconductive properties, that 
is easy to achieve and unlimitedly available, biocompatible and 
reabsorbable, immunologically inert, affordable, and that favors 
bone tissue neoformation despite of the presence of local tis-
sue changes and systemic diseases. There is clearly a long 
road to go.
The present study is aimed to assess the osteoinductive ef-
fect of growth factors present on platelet-rich plasma (PRP) 
when associated to ceramics on bone neoformation process 
of rats’ spine.
283282 Acta Ortop Bras. 2009; 17(5):282-5Acta Ortop Bras. 2009; 17(5):282-5
Figure 1 (a) – Histologic slide stained with Hematoxylin-eosin (magnification: 
200 x), showing a bone neoformation area adjacent to vertebral canal in an 
animal of the study group.
Figure 1 (b) – Image processed on UTHSCSA’s (The University of Texas 
Health Science Center in San Antonio) Image Tool software, from the previ-
ous (a), where histological elements different from bone were excluded for 
subsequent histometric measurement of the area.
MATERIALS AND METHODS
The experimental model constituted of male adult isogenic Lewis 
rats weighting 300 g in average. The use of isogenic animals 
produces a homogenous sample and allows for reducing it, 
which makes study development easier. Thus, two groups (study 
and control) were built  with seven animals each. Two rats were 
separately used for obtaining PRP. 
Surgical procedures were performed at the same day by the 
researcher, The animals were anesthetized with intramuscular 
injection of 2% xylazine and 5% ketamine at a proportion of 
1:0,2 ml/ 100 g. A skin incision at the level of iliac crests was 
made on lumbar region with subsequent dissection of fascias, 
muscular aponeurosis exposure, subperiostal dissection of the 
paravertebral musculature and laminectomy of two continuous 
levels of the spine. The wounds were temporarily covered and 
PRP was prepared separately by centrifuging the blood collected 
from two other rats, obtained by direct catheterism of the aorta 
exposed by thoracolaparotomy.
The software employed in this study was the Smart Prep (Harvest 
Technologies Inc., Plymouth, MA). Study and control groups 
were randomly determined. PRP was activated by adding cal-
cium gluconate at a proportion of 1:10 and the resulting clog 
was immediately combined with the ceramics (Osteosynt, Einco 
Biomaterial Ltda., Belo Horizonte,MG). The animals in the study 
group received ceramic graft with PRP and control group ani-
mals, only ceramics. The wounds were closed at two planes and 
the animals were postoperatively kept in the animal lab for 10 
weeks, at uniform lighting and temperature conditions and with 
water and food ad libitum. After that period, the animals were 
sacrificed with a lethal injection and their spines removed in 
block on the operated segments for anatomical-pathological 
study. Stains used for the analysis were Hematoxylin-eosin and 
Masson trichrome. The anatomical-pathological analysis of the 
material comprehended two phases: 
1) Qualitative study, where histopathological aspects of the bone 
neoformation process were assessed: presence of loose con-
nective tissue, cartilaginous and bone tissue, and respective 
proportions; osteogenic and osteoclastic activity; presence and 
type of associated inflammatory process and ceramic’s degree 
of reabsorption.
2) Quantitative study. This was conducted with the aid of an 
analysis digital system consisting of an Olympus BX40 micro-
scope with plan-achromatic objective lenses attached to an Oly 
video camera and to an Intel Celeron, 768 Mhz / 1,00 GB RAM 
personal computer with built-in image digitalizer plate running 
with an UTHSCA (The University of Texas Health Science Center 
in San Antonio) Image Tool software release 3.0. Images were 
captured with 200 x magnification, to view the whole opera-
tive bed. Once captured, digitalized images were processed on 
Adobe Photoshop 7.0, with the aid of the “eraser” tool, erasing 
all non-bone structures of the image. From that processed im-
age, bone area was measured with the Image Tool software, with 
the value expressed as squared micrometers and exporting it 
to an Excel sheet. 
RESULTS
The histopathological analysis evidenced differences between 
groups. In the study group, topic and heterotopic bone tissue 
neoformation was found, sometimes as a continuation with car-
tilaginous tissue (endochondral ossification), strong osteoblastic 
and osteoclastic activity with signs of bone remodeling with sev-
eral bone cement lines restitutio ad integrum of the bone marrow 
and full reabsorption of the implanted ceramics (Figure 1A,1B ). 
On control group, small islands of mature bone were observed 
around loose connective tissue, with a subtler osteoblastic activ-
ity, but no osteoclastic activity and with a large portion of non-
reabsorbed ceramics (Figure 2A,2B). Specific and non-specific 
inflammatory process was found on both groups, randomly. The 
mean area values measured by histometry were higher in the 
study group as compared to the control group.
The histometric values measured for both groups are presented 
on Table 1.
Table 1 – Histometry (in squared micrometers)
Study Group Control Group
Animal 1 4587291 1974169
Animal 2 11161126 6293622
Animal 3 4586735 5242105
Animal 4 10101187 5251582
Animal 5 4291024 1767348
Animal 6 2756362 3704697
Animal 7 26564948 3114449
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Figure 2 (a) – Histologic slide stained with Hematoxylin-eosin (magnification: 
200 x), showing a bone neoformation area adjacent to vertebral canal in an 
animal of the control group.
Figure 2 (b) – Image processed on UTHSCSA’s (The University of Texas 
Health Science Center in San Antonio) Image Tool software, from the previ-
ous (a), where histological elements different from bone were excluded for 
subsequent histometric measurement of the area.
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DISCUSSION
Blood platelets contain essential proteins that are released to 
start the healing process of any wound in human body: the 
platelet-derived growth factor (PDGF, released as three isomer-
ic forms: PDGFαα, PDGFββ and PDGFαβ), the transforming 
growth factors (TGF, TGFβ1 and TGFβ2 variants), the vascular 
endothelium growth factor (VEGF) and the epithelial growth fac-
tor (EGF). 
PDGF is the first growth factor released upon any tissue lesion. 
Its action triggers connective tissue induction and differentiation 
process, ultimately leading to lesion repair. PDGF’s specific ac-
tivities include enhancement of mitogenesis and angiogenesis 
and macrophages activation, which are responsible for early 
debridement of the wound through cell degradation residues 
phagocytosis. Subsequently, these cells will also release PDGF, 
perpetuating the osteoinductive stimulation and local differentia-
tion of mesenchymal cells. Blood platelets are PDGF-rich; about 
1200 molecules of this growth factor are estimated to be pre-
synthesized on the granules of a single platelet.
TGFβ1 and TGFβ2 belong to the same family as bone mor-
phogenetic proteins (BMP). They are similarly synthesized by 
macrophages and other cells, and, when released, have a para-
crine action over fibroblasts, mesenchymal cells of bone marrow 
and pre-osteoblasts. Their specific actions include mitogenesis 
stimulation, chemotaxis of osteoprogenitor cells, osteoblasts 
stimulation to release collagen matrix for osteoid formation and 
osteoclastic activity inhibition.
Considering the properties of the growth factors found on platelets, 
and having in mind that at least two of them (PDGF and TGF) 
stimulate osteoblastic activity7 and, whereas TGF comprehends 
in its family all BMP variables8, it is reasonable to assume that 
these growth factors have a similar osteoinductive ability to that 
attributed to BMP. Thus, these factors could have an enhanced 
osteoinductive ability by obtaining a blood platelet concentrate 
when deposited into a bone continuity solution.
PRP consists of an autologous platelet concentrate into a small 
plasma volume, obtained from centrifugation, which separates 
platelets from other blood elements without damaging them. 
PDGF and TGF levels were identified and quantified by radioim-
mune assay (ELISA) by Landsberg.9 Haynesworth et al.10 found 
a correlation between osteoinductive ability and local concentra-
tion of platelets, establishing osteoinductive platelet concentra-
tion as 1.000.000/ ml PRP.
Growth factors are released by platelet degranulation and act 
by binding to osteoblasts, fibroblasts, endothelial and epithelial 
cell surfaces through membrane receptors, of which activation 
results in the induction of proteins into cell cytoplasm, which, in 
turn, stimulates the expression of a characteristic genetic se-
quence of the cell. The resulting protein synthesis implies in cell 
proliferation and collagen synthesis for bone matrix or osteoid 
formation. Thus, growth factors do not penetrate the cell or are 
mutagenic: they simply at as stimulating factors to physiologic 
growth processes. Platelets keep osteoinductive stimulus for 
seven days, then experience degradation. Osteoinduction is 
taken from there by previously activated macrophages.
Obtaining PRP and recognizing its osteoinductive properties is a 
recent matter of study. There are few experimental studies, and 
its clinical application is now starting to be assessed in some 
situations. Marx et al.8 and Kassolis et.11 report a clinical use for 
PRP in preparing jaw grafts in various situations and in the ossifi-
cation of dental implants, just like Garg12 and Anitua13, with good 
results. Man et al.14 and Abuzeni et al.15 suggest using it in Plastic 
Surgery, reporting improved and earlier healing, with superior 
clinical evolution and cosmetic outcome in incisions where PRP 
is used as a sealing agent. Fennis et al.16 reported significant 
outcomes in an experimental study conducted on goats, where 
animals’ jaw osteotomy kept with rigid fixation showed superior 
bone repair when grafts were added by PRP. Aghaloo et al.17 
found better bone neoformation in New Zealand rabbits’ calvaria 
using PRP versus autologous repair.
To date, we haven’t found any publication in literature involving 
the use of PRP associated to ceramics in the repair of spinal 
osteotomies on any animal experimental model. The present 
study is a novelty in this sense.
Histopathological findings reported in our study for the study 
group are similar to those described by literature where ceram-
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ics is associated to some kind of BMP, usually rhBMP-2. From 
the eighth evolution week, the animals are going through re-
absorption and remodeling phase of the bone repair process, 
with mature bone formation distributed as trabeculae and ap-
posed lamellas and bone marrow restructuring ad integrum. 
There are osteoclasts and osteoblasts present, as well as bone 
remodeling signs with several bone cement lines and full ce-
ramic reabsorption. On control group, loose or fibrous tissue was 
found permeating small islands of bone tissue of various sizes 
and a large amount of granules of non-reabsorbed ceramics. 
Histometry compared by the mean bone areas measurement 
was three times higher in the study group than in control group. 
Therefore, PRP may potentially have accelerated bone neofor-
mation process on the study group, justifying ceramic graft’s 
full reabsorption and the better organized tissue appearance, 
with more evident remodeling. An earlier mature bone formation 
might mean an accelerated and more effective fusion process, 
which encourages us to conduct further studies on more evolved 
animals aiming to extrapolate the synergistic association of ce-
ramics and PRP to future clinical studies.
CONCLUSION
The use of PRP associated to ceramics as synergistic grafting 
in spine osteotomies of isogenic rats has evidenced marked 
histopathological differences when compared to ceramic graft-
ing alone. Stronger osteoblastic and osteoclastic activity, better 
tissue structuring of newly-formed bone and full ceramics reab-
sorption were found with the use of PRP.
